113 results on '"Priola, Suzette A."'
Search Results
2. β-Barrel proteins tether the outer membrane in many Gram-negative bacteria
3. Processing of high-titer prions for mass spectrometry inactivates prion infectivity
4. The PINK1/Parkin pathway of mitophagy exerts a protective effect during prion disease.
5. Anchorless Priori Protein Results in Infectious Amyloid Disease without Clinical Scrapie
6. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes
7. Interactions between Heterologous Forms of Prion Protein: Binding, Inhibition of Conversion, and Species Barriers
8. Porphyrin and Phthalocyanine Antiscrapie Compounds
9. Efficacy of Wex-cide 128 disinfectant against multiple prion strains.
10. Full-length prion protein incorporated into prion aggregates is a marker for prion strain-specific destabilization of aggregate structure following cellular uptake.
11. Uptake and Degradation of Protease-Sensitive and -Resistant Forms of Abnormal Human Prion Protein Aggregates by Human Astrocytes
12. Cell biology of prion strains in vivo and in vitro.
13. Rabbits are not resistant to prion infection
14. Disinfection and Sterilization of Prion‐Contaminated Medical Instruments
15. Susceptibility of Common Fibroblast Cell Lines to Transmissible Spongiform Encephalopathy Agents
16. Prophylactic and Therapeutic Effects of Phthalocyanine Tetrasulfonate in Scrapie-Infected Mice
17. Species Specificity in the Cell-Free Conversion of Prion Protein to Protease-Resistant Forms: A Model for the Scrapie Species Barrier
18. Susceptibilities of nonhuman primates to chronic wasting disease
19. Lack of the immune adaptor molecule SARM1 accelerates disease in prion infected mice and is associated with increased mitochondrial respiration and decreased expression of NRF2.
20. Antiaggregating Antibody Raised Against Human PrP 106-126 Recognizes Pathological and Normal Isoforms of the Whole Prion Protein
21. Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems: An update
22. Toxicity and Protection in Prions
23. A View from the Top: Prion Diseases from 10,000 Feet
24. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans
25. Molecular Aspects of Disease Pathogenesis in the Transmissible Spongiform Encephalopathies
26. Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation
27. Antiscrapie Drug Action
28. Inhibition of scrapie-associated PrP accumulation: Probing the role of glycosaminoglycans in amyloidogenesis
29. Cell-free formation of protease-resistant prion protein
30. Prions
31. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
32. Amyloid formation via supramolecular peptide assemblies
33. Identification of possible animal origins of prion disease in human beings
34. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
35. Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity.
36. Relative Abundance of apoE and Aβ1–42 Associated with Abnormal Prion Protein Differs between Creutzfeldt-Jakob Disease Subtypes.
37. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
38. Treatment of Prion Disease with Heterologous Prion Proteins.
39. Proteomics applications in prion biology and structure.
40. A Specific Population of Abnormal Prion Protein Aggregates Is Preferentially Taken Up by Cells and Disaggregated in a Strain- Dependent Manner.
41. Lack of Prion Infectivity in Fixed Heart Tissue from Patients with Creutzfeldt-Jakob Disease or Amyloid Heart Disease.
42. Recombinant Prion Protein Refolded with Lipid and RNA Has the Biochemical Hallmarks of a Prion but Lacks In Vivo Infectivity.
43. Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure.
44. Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations.
45. The role of the prion protein membrane anchor in prion infection.
46. Endocytosis of Prion Protein Is Required for ERK1/2 Signaling Induced by Stress-Inducible Protein 1.
47. Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity.
48. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein.
49. DNA Aptamers That Bind to PrP C and Not Prp Sc Show Sequence and Structure Specificity.
50. Flexible N-terminal Region of Prion Protein Influences Conformation of Protease-resistant Prion Protein Isoforms Associated with Cross-species Scrapie Infection in Vivo and in Vitro.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.